Anikó Barta

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar et al. · Bone Marrow Transplantation · 2018 · 107 citations · Full text

Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation “MSC-FFM”—Outcome Report of 92 Patients

Halvard Bönig, Zyrafete Kuçi, Selim Kuçi et al. · Cells · 2019 · 66 citations · Full text

Cell Therapy, Immunology, Immunotherapy +17

Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

Nóra Meggyesi, András Kozma, Gabriella Halm et al. · Acta Haematologica · 2011 · 30 citations

Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF

Péter Reményi, László Gopcsa, Imelda Marton et al. · Advances in Therapy · 2014 · 26 citations

Regenerative Medicine, Biosimilar Rhg-csf, Transplantation +9

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts

Hajnalka Andrikovics, Sarolta Nahajevszky, Anikó Szilvási et al. · Hematological Oncology · 2007 · 26 citations